Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/6/22 17:08 | 6/2/22 | KOD | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 4,448 | 7.77 | 0 | 572 | 4 | 15,968 | I | |||||||||||||||
5/18/22 17:30 | 5/16/22 | KOD | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 2,697 | 5.91 | 0 | 457 | 3 | 15,142 | I | |||||||||||||||
2/17/22 17:33 | 2/15/22 | KOD | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 21,832 | 54.45 | 0 | 401 | 3 | 14,735 | I | |||||||||||||||
1/31/22 17:06 | 1/27/22 | KOD | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 18,085 | 52.02 | 0 | 348 | 2 | 14,365 | I | |||||||||||||||
1/25/22 17:40 | 1/21/22 | KOD | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 28,807 | 57.49 | 0 | 501 | 3 | 15,182 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |